DUBLIN, October 5, 2021 / PRNewswire / – The “Global Biosurgery Market 2021-2028” report has been added to ResearchAndMarkets.com offer.

According to this report, the global biosurgery market is expected to grow at a CAGR of 6.21% during the projected period 2021-2028.

Over the years, technological advancements and innovations in healthcare facilities have led to the rise of biosurgery in various countries. Here, biosurgery plays a vital role as an alternative to conventional open surgery. Hence, technological advancements besides increasing geriatric population are expected to widen the scope and growth of the biosurgery market over the next few years.

However, the high cost of the surgeries, coupled with the complications related to the immune response, are significant factors weighing on the advancement of the biosurgery market globally.

The global biosurgery market covers North America, Latin America, Asia Pacific, Europe, and the Middle East and Africa Regions.
Overall, the Asia Pacific is expected to become the fastest growing region in the biosurgery market during the forecast period. The strong growth of the region can be attributed to various factors, such as the increasing burden of chronic diseases, the increasing number of surgeries and the development of new products. Besides, the prevalence of various living conditions and the increase in the geriatric population are another set of factors that are expected to increase the demand for biosurgery products, thereby driving the biosurgery market on a growth path.

Distinguished companies in the biosurgery market include B Braun Melsungen AG, CSL Limited, Medtronic Plc, Smith & Nephew Plc, Zimmer Biomet Holdings Inc, Becton, Dickinson And Company, Integra Lifesciences Holdings Corporation, RTI Surgical, Ethicon Inc (Johnson & Johnson), Stryker Corporation, Wright Medical Group NV, Baxter International Inc and Sanofi.

The story continues

Becton, Dickinson and Company is a global medical technology company involved in the development, manufacture and sale of medical devices, laboratory equipment and diagnostic products. Its product portfolio includes syringes and needles for pens, infusion pumps, hemostats and other products. The company offers its products to life science researchers, health institutes, clinical laboratories and pharmaceutical companies. It operates in various regions, including Asia Pacific and Europe, headquartered at United States.

Main topics covered:

1. Global Biosurgery Market – Summary

2. Industry outlook
2.1. Impact of COVID-19 on the biosurgery market
2.2. Trends in biosurgery technology
2.3. Key ideas
2.4. Porter’s five forces model
2.4.1. The threat of new participants
2.4.2. Threat of substitute products
2.4.3. The bargaining power of buyers
2.4.4. Bargaining power of suppliers
2.4.5. Competitive rivalry
2.5. Market attractiveness index
2.6. Supplier scorecard
2.7. Key buying prospects
2.8. Key market strategies
2.8.1. Contracts and partnerships
2.8.2. Business expansions, announcements and divestitures
2.8.3. Acquisitions & Mergers
2.8.4. New product launches and developments
2.9. Market factors
2.9.1. Growing aging population
2.9.2. Technological advances and innovations in healthcare establishments
2.9.3. Increase in surgical treatments for musculoskeletal disorders
2.9.4. Prevalence of spinal fusion and joint reconstruction
2.9.5. Strong focus on research and development
2.10. Market challenges
2.10.1. High cost of surgeries
2.10.2. Complications related to the immune response
2.10.3. Use of minimally invasive surgeries
2.11. Market opportunities
2.11.1. Research and investments in bioengineering
2.11.2. Development of reimbursement and compensation policies

3. Global Biosurgery Market – By Product
3.1. Hemostatic agents
3.2. Bone graft substitutes
3.2.1. Synthetic graft extensions
3.2.2. Demineralized bone matrix
3.2.3. Bone morphogenetic proteins
3.2.4. Cell-based matrices
3.3. Surgical sealants
3.3.1. Natural
3.3.2. Synthetic
3.4. Soft tissue management
3.4.1. Mesh / Synthetic Patch
3.4.2. Mesh / Natural Patch
3.5. Non-stick agents
3.6. Reinforcement of the stapling line

4. Global Biosurgery Market – By Application
4.1. Orthopedic surgery
4.2. Cardio and Thoracic Surgery
4.3. Neuro and spine surgery
4.4. General surgery
4.5. Other applications

5. Global Biosurgery Market – By Source Type
5.1. Natural
5.2. Synthetic

6. Global Biosurgery Market – Regional Outlook

7. Competitive landscape
7.1. Baxter International Inc
7.2. Becton, Dickinson and company
7.3. B Braun Melsungen AG
7.4. Csl Limited
7.5. Ethicon Inc (Johnson & Johnson)
7.6. Holding company Integra Lifesciences
7.7. Medtronic plc
7.8. Rti Surgical
7.9. Sanofi
7.10. Smith & Nephew plc
7.11. Stryker Company
7.12. Wright Medical Group Nv
7.13. Zimmer Biomet Holdings Inc

8. Methodology and scope of the research

For more information on this report, visit https://www.researchandmarkets.com/r/assypc

Media contact:

Research and markets
Laura Wood, senior
[email protected]

For EST office hours, call + 1-917-300-0470
For USA / CAN call toll free + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900

US Fax: 646-607-1904
Fax (outside the United States): + 353-1-481-1716

View original content: https://www.prnewswire.com/news-releases/worldwide-biosurgery-industry-to-2028—by-product-application-source-type-and-region-301393213.html

SOURCE Research and Markets